Cargando…
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
BACKGROUND: Transarterial chemoembolization (TACE) therapy is an effective locoregional treatment in hepatocellular cancer (HCC) patients. For early modification of therapy, markers predicting therapy response are urgently required. METHODS: Here, sera of 50 prospectively and consecutively included...
Autores principales: | Kohles, Nikolaus, Nagel, Dorothea, Jüngst, Dietrich, Durner, Jürgen, Stieber, Petra, Holdenrieder, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118895/ https://www.ncbi.nlm.nih.gov/pubmed/21615953 http://dx.doi.org/10.1186/1471-2407-11-202 |
Ejemplares similares
-
Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy
por: Fahmueller, Yvonne Nadine, et al.
Publicado: (2012) -
Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments
por: Mueller, Susanne, et al.
Publicado: (2006) -
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015) -
Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer
por: Gezer, Ugur, et al.
Publicado: (2015) -
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
por: McAnena, Peter, et al.
Publicado: (2017)